Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - granules - 8.75 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - granules - 8.75 milligram

Israel - English - Ministry of Health

reckitt benckiser (near east) ltd - flurbiprofen - lozenges - flurbiprofen 8.75 mg - flurbiprofen - flurbiprofen - for the short term relief of symptoms of sore throat such as throat pain and soreness in adults and children over the age of 12 years

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - lozenge - 8.75 milligram(s) - other throat preparations; flurbiprofen

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - lozenge - 8.75 milligram(s) - other throat preparations; flurbiprofen

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - oromucosal spray, solution - 8.75 milligram(s)/dose - other throat preparations; flurbiprofen

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - flurbiprofen - oromucosal spray, solution - 8.75 milligram(s)/dose - other throat preparations; flurbiprofen

United States - English - NLM (National Library of Medicine)

stat rx usa llc - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - flurbiprofen 100 mg - carefully consider the potential benefits and risks of flurbiprofen tablets and other treatment options before deciding to use flurbiprofen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). flurbiprofen tablets are indicated: - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. flurbiprofen tablets are contraindicated in patients with known hypersensitivity to flurbiprofen tablets or the excipients (see description). flurbiprofen should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other non-steroidal anti-inflammatory drugs. severe, rarely fatal, anaphylactic-like reactions to non-steroidal anti-inflammatory drugs have been reported in such patients (see warnings: anaphylactoid reactions and precautions: general: preexisting asthma). flurbiprofen is contraindicated for the treatment

Singapore - English - HSA (Health Sciences Authority)

reckitt benckiser (singapore) pte ltd - flurbiprofen - lozenge - 8.75mg - flurbiprofen 8.75mg

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - flurbiprofen 100 mg - carefully consider the potential benefits and risks of flurbiprofen tablets and other treatment options before deciding to use flurbiprofen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). flurbiprofen tablets are indicated: - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. flurbiprofen tablets are contraindicated in patients with known hypersensitivity to flurbiprofen tablets or the excipients (see description). flurbiprofen should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other non-steroidal anti-inflammatory drugs. severe, rarely fatal, anaphylactic-like reactions to non-steroidal anti-inflammatory drugs have been reported in such patients (see warnings: anaphylactoid reactions and precautions: general: preexisting asthma ). flurbiprofen is contraindicated for the treatment of peri